SCHEMBL6562826

SCHEMBL6562826

O=C(Nc1cc(-c2ccccc2)[nH]n1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 1.00
RAB9A P51151 4/20 1.00
MAPT P10636 1/20 0.84
ALPL P05186 1/20 0.72
ALPI P09923 1/20 0.72
MEN1 O00255 1/20 0.70
LMNA P02545 1/20 0.70
PKM P14618 1/20 0.70
MAPK1 P28482 1/20 0.70
KMT2A Q03164 1/20 0.70
CCNA2 P20248 2/20 0.66
CDK2 P24941 2/20 0.66
CCNA1 P78396 2/20 0.66
EIF2AK2 P19525 1/20 0.65
CSNK2A2 P19784 1/20 0.62
CSNK2A1 P68400 1/20 0.62
NPY5R Q15761 2/20 0.59
BCHE P06276 1/20 0.58
ACHE P22303 1/20 0.58
HDAC1 Q13547 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663611 0.94 NPC1 (0.89) NPC1RAB9AMAPTALPLALPI
SCHEMBL6566353 0.91 NPC1 (1.00) NPC1RAB9AMAPTALPLALPI
SCHEMBL7514363 0.88 NPC1 (0.78) NPC1RAB9AMAPTALPLALPI
SCHEMBL29466507 0.83 MEN1 (0.78) NPC1RAB9AMAPTALPLALPI
SCHEMBL4264906 0.82 ALPL (0.78) NPC1RAB9AMAPTALPLALPI
SCHEMBL1665225 0.82 RAB9A (0.69) NPC1RAB9AMAPTALPLALPI
SCHEMBL6565951 0.81 ALPL (0.76) NPC1RAB9AMAPTALPLALPI
SCHEMBL6564725 0.81 RAB9A (1.00) NPC1RAB9AMAPTALPLALPI
SCHEMBL17283670 0.81 CCNA2 (0.69) NPC1RAB9AMAPTALPLALPI
SCHEMBL1664228 0.81 RAB9A (0.68) NPC1RAB9AMAPTALPLALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788358-B1 USE OF PYRAZOLE COMPOUNDS FOR THE TREATMENT OF GLOMERULONEPHRITIS, CANCER, ATHEROSCLEROSIS OR RESTENOSIS MILLENNIUM PHARM INC (US) 2004-03-31 EP disclosed
US-5916908-A Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases COR THERAPEUTICS, INC. (US) 1999-06-29 US disclosed
CN-1165482-A Pyrazole pharmaceutical compositions as protein kinase inhibitors COR THERAPEUTICS INC (US) 1997-11-19 CN disclosed
EP-0788358-A2 PHARMACEUTICAL PYRAZOLE COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES COR THERAPEUTICS, INC. (US) 1997-08-13 EP disclosed
WO-1996014843-A2 PHARMACEUTICAL PYRAZOLE COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES COR THERAPEUTICS, INC. (US) 1996-05-23 WO disclosed